Menggang Yu Selected Research

Menggang Yu Research Topics

Disease

38	Neoplasms (Cancer) 11/2022 - 08/2002
10	Breast Neoplasms (Breast Cancer) 01/2018 - 07/2009
6	Prostatic Neoplasms (Prostate Cancer) 11/2021 - 08/2002
5	Neoplasm Metastasis (Metastasis) 12/2017 - 01/2014
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2013 - 04/2008
4	Carcinoma (Carcinomatosis) 01/2022 - 06/2013
4	Disease Progression 01/2020 - 02/2005
3	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 06/2009
3	Carcinogenesis 01/2019 - 03/2010
3	Esophageal Neoplasms (Esophageal Cancer) 01/2019 - 11/2013
3	Inflammation (Inflammations) 01/2018 - 03/2010
3	Hypersensitivity (Allergy) 07/2012 - 05/2005
2	Colorectal Neoplasms (Colorectal Cancer) 12/2018 - 01/2012
2	Exanthema (Rash) 10/2013 - 01/2012
2	Thromboembolism 12/2012 - 12/2012
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 12/2012 - 06/2009
2	Neutropenia 12/2012 - 02/2008
2	Juvenile Myelomonocytic Leukemia 07/2012 - 05/2005
2	Hot Flashes 05/2012 - 07/2009
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010 - 01/2009
1	Oropharyngeal Neoplasms 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Frailty 01/2022
1	Lymphoma (Lymphomas) 10/2021
1	Heart Failure 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Abdominal Aortic Aneurysm 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Laryngeal Neoplasms (Laryngeal Cancer) 11/2017
1	Squamous Cell Carcinoma of Head and Neck 11/2017
1	Circulating Neoplastic Cells 01/2017
1	Adenocarcinoma 11/2016
1	Extranodal Extension 11/2016

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2012
6	Pharmaceutical PreparationsIBA 09/2021 - 05/2005
5	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 12/2012
4	coactivator-associated arginine methyltransferase 1IBA 11/2016 - 01/2014
3	AndrogensIBA 11/2021 - 11/2016
3	Gemcitabine FDA Link 01/2018 - 10/2011
3	Protein Isoforms (Isoforms)IBA 01/2015 - 07/2013
3	Cetuximab (Erbitux)FDA Link 11/2013 - 11/2009
3	Sorafenib (BAY 43-9006)FDA Link 10/2013 - 06/2009
3	Bevacizumab (Avastin)FDA Link 10/2013 - 12/2010
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013 - 02/2008
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 07/2012 - 05/2005
3	Docetaxel (Taxotere)FDA Link 01/2012 - 02/2008
2	thiamine triphosphorate (TTP)IBA 04/2022 - 11/2009
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Phenobarbital (Luminal)FDA Link 11/2021 - 12/2017
2	AntibodiesIBA 12/2018 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 12/2018 - 04/2008
2	CollagenIBA 01/2018 - 01/2017
2	Prostate-Specific Antigen (Semenogelase)IBA 11/2016 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 01/2015 - 01/2014
2	Sunitinib (Sutent)FDA Link 06/2013 - 11/2012
2	Transaminases (Aminotransferases)IBA 12/2012 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 07/2009
2	Tryptophan (L-Tryptophan)FDA Link 01/2012 - 07/2009
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2010 - 08/2010
2	NF-kappa B (NF-kB)IBA 03/2010 - 06/2009
2	taxaneIBA 12/2009 - 02/2008
2	Pemetrexed (MTA)FDA Link 11/2009 - 01/2009
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	PlatinumIBA 01/2020
1	pembrolizumabIBA 01/2020
1	AntioxidantsIBA 01/2019
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019
1	PowdersIBA 01/2019
1	Sunscreening Agents (Sunscreens)IBA 01/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2019
1	Estrogen ReceptorsIBA 09/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2018
1	IpilimumabIBA 01/2018
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2018
1	Biological ProductsIBA 12/2017
1	Androgen Receptors (Androgen Receptor)IBA 12/2017
1	Janus KinasesIBA 01/2017
1	Green Fluorescent ProteinsIBA 01/2017
1	Estrogen Receptor alphaIBA 01/2017
1	Prolactin Receptors (Prolactin Receptor)IBA 01/2017
1	ProlactinIBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 11/2016

Therapy/Procedure

15	Therapeutics 04/2022 - 06/2009
13	Drug Therapy (Chemotherapy) 10/2021 - 04/2008
7	Radiotherapy 01/2019 - 02/2005
5	Chemoradiotherapy 01/2022 - 12/2010
3	Immunotherapy 11/2022 - 12/2018
2	Castration 11/2021 - 09/2021
2	Patient Readmission 01/2021 - 12/2014
2	Prostatectomy (Retropubic Prostatectomy) 11/2016 - 08/2002
1	Precision Medicine 04/2022
1	Ambulatory Care (Outpatient Care) 01/2022
1	Aftercare (After-Treatment) 11/2021
1	Neoadjuvant Therapy 01/2019
1	Operative Surgical Procedures 01/2019
1	Treatment Delay 12/2018
1	Transplantation 01/2017